Charles C. J. Carpenter

14.2k citations

141 papers · 11.0k indexed · 6 hit papers · h-index 50

Infectious Diseases top 0.05%
Virology top 0.05%
Epidemiology top 0.5%
Emergency Medicine top 0.2%
Molecular Biology top 10%

Co-authors: David Katzenstein Robert T. Schooley Melanie Thompson Martin Hirsch Douglas D. Richman Donna M. Jacobsen Stefano Vella Michael S. Saag
Topics: HIV/AIDS Research and Interventions (48 papers)HIV Research and Treatment (32 papers)HIV/AIDS drug development and treatment (26 papers)
Cited by: Virology Infectious Diseases Emergency Medicine
Journals: Science New England Journal of Medicine The Lancet
Partner nations: United States India United Kingdom

In The Last Decade

Charles C. J. Carpenter

136 papers receiving 10.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral Therapy in Adults

2000 874 citations Charles C. J. Carpenter et al. JAMA profile →
Antiretroviral Therapy for HIV Infection in 1998

1998 837 citations Charles C. J. Carpenter et al. JAMA profile →
Treatment for Adult HIV Infection

2006 767 citations Charles C. J. Carpenter et al. JAMA profile →
Treatment for Adult HIV Infection

2004 601 citations Charles C. J. Carpenter et al. JAMA profile →
Antiretroviral Therapy for HIV Infection in 1997

1997 579 citations Charles C. J. Carpenter JAMA profile →
Antiretroviral Treatment for Adult HIV Infection in 2002

2002 573 citations Charles C. J. Carpenter et al. JAMA profile →

Peers

Countries citing papers authored by Charles C. J. Carpenter

Since Specialization

Citations

This map shows the geographic impact of Charles C. J. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles C. J. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles C. J. Carpenter more than expected).

Fields of papers citing papers by Charles C. J. Carpenter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles C. J. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles C. J. Carpenter. The network helps show where Charles C. J. Carpenter may publish in the future.

Co-authorship network of co-authors of Charles C. J. Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of Charles C. J. Carpenter. A scholar is included among the top collaborators of Charles C. J. Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles C. J. Carpenter. Charles C. J. Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MMMORRF: Multimodal Multilingual MOdularized Reciprocal Rank Fusion 2025 ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Andrew Yates,Eugene Yang,Charles C. J. Carpenter,(unknown),(unknown),(unknown),Kenton Murray,(unknown)	0
2	Performances on the CogState and Standard Neuropsychological Batteries Among HIV Patients Without Dementia 2011 ·AIDS and Behavior ·Edgar T. Overton,John S. K. Kauwe,Robert Paul,Karen T. Tashima,David F. Tate,Pragna Patel,Charles C. J. Carpenter,(unknown),John T. Brooks,David B. Clifford	47
3	The Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study) 2008 ·American Journal of Epidemiology ·Claudia Vellozzi,J. T. Brooks,Timothy J. Bush,Lois Conley,Keith Henry,Charles C. J. Carpenter,Edgar T. Overton,John Hammer,Kathleen C. Wood,Scott D. Holmberg,(unknown)	52
4	Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge 2006 ·Clinical Infectious Diseases ·David N. Taylor,R. McKenzie,Anna P. Durbin,Charles C. J. Carpenter,(unknown),R Haake,A. Louis Bourgeois	50
5	Routine Testing for HIV in the United States: The Intersection Between Recommendations and Practice 2006 ·AIDS Patient Care and STDs ·Emma Simmons,Mary B. Roberts,Mindy Ma,Curt G. Beckwith,Charles C. J. Carpenter,Timothy Flanigan	14
6	Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients 2005 ·AIDS ·Nagalingeswaran Kumarasamy,Snigdha Vallabhaneni,Timothy Flanigan,Pachamuthu Balakrishnan,Anitha J. Cecelia,Charles C. J. Carpenter,Suniti Solomon,Kenneth H. Mayer	19
7	Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine 2004 ·Methods ·Anne S. De Groot,Elizabeth Bishop,(unknown),Michelle Lally,Luisa Marcon,(unknown),Kenneth H. Mayer,Charles C. J. Carpenter,William Martin	40
8	Development of Proteinuria or Elevated Serum Creatinine and Mortality in HIV-Infected Women 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Lytt I. Gardner,Scott D. Holmberg,John Williamson,Lynda A. Szczech,Charles C. J. Carpenter,Anne Rompalo,Paula Schuman,Robert S. Klein	137
9	Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence 2003 ·AIDS ·Joseph I. Harwell,Timothy Flanigan,Jennifer A. Mitty,Grace Macalino,Angela M. Caliendo,Jessica Ingersoll,Molly Stenzel,Charles C. J. Carpenter,Susan Cu‐Uvin	6
10	Monitoring HIV treatment in the developing world 2002 ·The Lancet Infectious Diseases ·N. Kumarasamy,Timothy Flanigan,Anish P. Mahajan,Charles C. J. Carpenter,Kenneth H. Mayer,Suniti Solomon	23
11	Antiretroviral Therapy for HIV Infection in 1997breakdown → 1997 ·JAMA ·Charles C. J. Carpenter	579
12	Human immunodeficiency virus infection and acquired immunodeficiency syndrome among north american women 1996 ·The American Journal of Medicine ·Susan Cu‐Uvin,Timothy Flanigan,Josiah D. Rich,Maria D. Mileno,Kenneth H. Mayer,Charles C. J. Carpenter	20
13	Infection with the human immunodeficiency virus in prisoners: Meeting the health care challenge 1993 ·The American Journal of Medicine ·(unknown),Timothy Flanigan,Barbara A. DeBuono,(unknown),(unknown),(unknown),Michael D. Stein,H. Denman Scott,Charles C. J. Carpenter	48
14	Causes of death in persons with human immunodeficiency virus infection 1992 ·The American Journal of Medicine ·Michael D. Stein,Patricia O’Sullivan,Tom J. Wachtel,Alvan Fisher,Dennis J. Mikolich,(unknown),(unknown),Charles C. J. Carpenter,Gail Skowron,Kenneth H. Mayer	49
15	The Treatment of Cholera: Clinical Science at the Bedside 1992 ·The Journal of Infectious Diseases ·Charles C. J. Carpenter	37
16	Pediatric cholera: Current concepts of therapy 1972 ·The Journal of Pediatrics ·Charles C. J. Carpenter,Norbert Hirschhorn	7
17	EXPERIMENTAL CHOLERA A CANINE MODEL 1966 ·The Lancet ·R. Bradley Sack,Charles C. J. Carpenter,Richard W. Steenburg,N. F. Pierce	37
18	TRUE CHOLERA VERSUS NON-CHOLERAIC DIARRHOEA. A CLINICAL AND BIOCHEMICAL COMPARISON. 1965 ·PubMed ·Charles C. J. Carpenter,P. P. Mitra,R. Bradley Sack,D Barua	4
19	PATHOPHYSIOLOGY OF CHOLERA. 1964 ·PubMed ·Charles C. J. Carpenter	15
20	GREEN COCONUT WATER: A READILY AVAILABLE SOURCE OF POTASSIUM FOR THE CHOLERA PATIENT. 1964 ·PubMed ·Charles C. J. Carpenter,A Mondal,P. P. Mitra,(unknown)	1

About Charles C. J. Carpenter

Charles C. J. Carpenter is a scholar working on Virology, Endocrinology and Infectious Diseases, having authored 141 papers that have together received 11.0k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (48 papers), HIV Research and Treatment (32 papers) and HIV/AIDS drug development and treatment (26 papers). The work is most often cited by research in Virology (4.4k citations), Infectious Diseases (6.8k citations) and Emergency Medicine (1.8k citations). Charles C. J. Carpenter has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include David Katzenstein, Robert T. Schooley, Melanie Thompson, Martin Hirsch, Douglas D. Richman, Donna M. Jacobsen, Stefano Vella, Michael S. Saag, Scott M. Hammer and Paul A. Volberding. Their work appears in journals such as Science, New England Journal of Medicine and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact